SEC Filing Details

SEC Filing Details

Document Details

Form
3
Filing Date
Mar 16, 2011
Document Date
Mar 10, 2011
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
ReShape Lifesciences
Issuer
Filer
Tweden Katherin
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE